ACE2 and COVID-19: This is consistent with the recent manuscript on the inactivated COVID-19 vaccine [19], which identified high levels of SCFA pathways and SCFA levels at baseline as the strongest microbial feature predictive of anti-Ace2 antibody levels following immunization.